feed,title,long_url,short_url
Benzinga,"At Higher Doses, Otonomy's OTO-413 Shows No Clinical Benefit In Hearing Loss",https://benzinga.com/general/biotech/22/10/29253686/at-higher-doses-otonomys-oto-413-shows-no-clinical-benefit-in-hearing-loss,https://bit.ly/3VAD3Vg
Benzinga,Why Are Albertsons Shares Gaining Today?,https://benzinga.com/m-a/22/10/29254394/why-are-albertsons-shares-gaining-today,https://bit.ly/3Cxg4le
